Cancer Related Funding Opportunities

Defense Health Program Department of Defense Breast Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)

The Fiscal Year 2021 (FY21) Defense Appropriations Bill has not been signed into law. Although FY21 funds have not been appropriated for the Department of Defense Breast Cancer Research Program (BCRP), the BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities. This pre-announcement should not be construed as an obligation by the Government.

The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense BCRP to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

Subject to the FY21 Congressional appropriation for BCRP funding, FY21 BCRP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the Program Announcements are released.

Applications submitted to the FY21 BCRP must address one or more of the following overarching challenges:

  • Prevent breast cancer (primary prevention)
  • Identify determinants of breast cancer initiation, risk, or susceptibility
  • Distinguish deadly from non-deadly breast cancers
  • Conquer the problems of overdiagnosis and overtreatment
  • Identify what drives breast cancer growth; determine how to stop it
  • Identify why some breast cancers become metastatic
  • Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
  • Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
  • Eliminate the mortality associated with metastatic breast cancer

More Information

October 2020 Application Deadlines

10/29/2020 - Pfizer Global Medical Grants: NSCLC Oncogene Driver Considerations in Testing & Treatment

Amount/Duration: Up to $250,000 over 2 years
Eligibility: entities with a mission related to healthcare professional education and/or healthcare improvement are eligible.
About: Grant support will focus on increasing understanding within the oncology community of biomarker testing and treatment decision-making in advanced or metastatic NSCLC.

Application Deadline: October 29, 2020

More Information

November 2020 Application Deadlines

11/20/2020 - Pancreatic Cancer Action Network: PanCAN Career Development Award

Amount/Duration: $200,000 over two years
Eligibility: Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD or equivalent) in the biomedical sciences or in a field applicable to health science research and may not currently be a candidate for a further doctoral degree.
At the start of the grant term on July 1, 2021, applicants must:
 Hold a faculty position with the title of assistant professor, instructor, research assistant professor or the equivalent.
 Have completed their most recent doctoral degree within the past 11 years.
 Have independent laboratory space as confirmed by his/her institution in the Letter of Institutional Support.
 Work at an academic, medical or research institution within the United States; there are no citizenship requirements.
 Not have currently or previously served as a principal investigator on major research awards or grants (e.g., NIH R01 or equivalent, totaling $500,000 or more).
 Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible. About: Award supports junior faculty to conduct pancreatic cancer research and establish successful career paths in the field. Proposed research may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer. Special consideration will be given to understudied areas in pancreatic cancer research.

Application Deadline: November 20, 2020

More Information

Please contact the Development Office’s Corporate and Foundation Relations team for assistance or questions regarding these RFPs: honour.harlowe@mountsinai.org / 646-605-8715

11/23/2020 - Movember & The Distinguished Gentleman’s Ride: First Responders Grant Program

Amount/Duration: Up to $171,500 over two years. Community organizations would be allowed to include up to 10% indirect costs.

Eligibility: Open to anyone/any organization that meets the Funding Eligibility as outlined in the RFP in any of the following participating countries: CAN, AUS, IRELAND, UK, US, NEW ZEALAND. Only organizations that are 501(c)(3) non-profit organizations, educational institutions or organizations that have a 501(c)(3) Fiscal Sponsor may apply.

About:

  • The intention is to embed approaches that are upstream and supportive of men who work and volunteer in environments with first responders in Canada, Australia, New Zealand, Ireland, United Kingdom, and the United States or military veterans in Canada and Australia only.
  • A minimum of eight programs will be funded with a focus on those programs that have already shown promise in improving mental health and/or suicide prevention outcomes for these groups (firefighters, paramedics, medical responders, police officers, military veterans) and to build the evidence for effective interventions

Application Deadline: November 23, 2020

More Information

Please contact the Development Office’s Corporate and Foundation Relations team for assistance or questions regarding these RFPs: honour.harlowe@mountsinai.org / 646-605-8715

11/30/2020 - American Association for Cancer Research: Clinical Oncology Research Training Fellowships

Amount/Duration: $100,000 over one year. Indirect costs for up to a maximum of 20 percent of total direct costs are permitted.
Eligibility: Must have a medical degree (including MD, DO, or MD/PhD), and not currently be a candidate for a further doctoral degree, have enrolled in an accredited hematology/oncology or radiation oncology fellowship program at an academic, medical, or research institution within the United States, must not be employees or subcontractors of a U.S. government entity or for-profit private industry or be clinical fellows applying from a U.S. government laboratory (e.g., NIH, CDC, FDA, etc.).
About: This fellowship is designed for early-career clinical scientists who hold a medical degree (MD, DO, or MD/PhD) and are interested in acquiring the knowledge and skills related to clinical trial design and execution from the perspective of the pharmaceutical industry. The fellow will gain real-world experience in clinical development, including drug development, clinical research, clinical trial design, and data analysis.

Application Deadline: November 30, 2020

More Information

Please contact the Development Office’s Corporate and Foundation Relations team for assistance or questions regarding these RFPs: honour.harlowe@mountsinai.org / 646-605-8715

December 2020 Application Deadlines

12/01/2020 - Desmoid Tumor Research Foundation: Research Grant Program

Amount/Duration: Up to $65,000 for a minimum of one year. Funds may only be used for personnel, supplies, equipment, and/or services. Use of funds for institutional overhead costs, indirect costs and project costs that are funded by other sources are strictly prohibited.
Eligibility: Applicants must have their MD, PhD, or equivalent degree, as well as sponsorship by a tax-exempt organization defined under section 501(c)(3) of the Internal Revenue Code.
About: Grants will be awarded for research that advances current scientific knowledge of desmoid tumors using science and creative clinical applications, as well as novel approaches that addresses potential leads based on prior research

Application Deadline: December 1, 2020

More Information

Please contact the Development Office’s Corporate and Foundation Relations team for assistance or questions regarding these RFPs: honour.harlowe@mountsinai.org / 646-605-8715

12/01/2020 - Damon Runyon Cancer Research Foundation: Physician-Scientist Training Award

Amount/Duration: Total of $460,000 over a period of four years. Funding will be allocated to the awardee’s institution each year for the support of the scientist. Funds are to be used for stipend and/or research expenses. No part of this grant can be used for indirect costs or institutional overhead.
Year 1 – $100,000, Year 2 – $110,000, Year 3 – $120,000, Year 4 – $130,000: (Total $460,000).
Eligibility: To be eligible, applicants must be an MD or DO only and have completed their residency and clinical training, be U.S. Specialty Board eligible prior to the award start date, and must not have more than three years of postdoctoral laboratory experience. Candidates must apply with a mentor.
About: Damon Runyon wishes to encourage more physicians to pursue research careers. To do so, the Foundation established a program designed to recruit outstanding U.S. Specialty Board eligible physicians into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training.

Application Deadline: December 1, 2020

More Information

Please contact the Development Office’s Corporate and Foundation Relations team for assistance or questions regarding these RFPs: honour.harlowe@mountsinai.org / 646-605-8715

12/01/2020 - Rivkin Center for Ovarian Cancer: Pilot Study Awards

Amount/Duration: Up to $75,000 over two years with the possibility of an additional $25,000 awarded in year two, upon evaluation of year one progress, contingent on availability of funds.
Funds are for direct costs only; institutional overhead and indirect costs will not be included in the award.
Eligibility: Investigators at the assistant, associate, or full professor level (or equivalent) are encouraged to apply.
About: The Rivkin Center is announcing funds for Pilot Study Awards to be allocated based on scientific merit. Pilot Study Awards support investigator initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered.

Application Deadline: December 1, 2020

More Information

Please contact the Development Office’s Corporate and Foundation Relations team for assistance or questions regarding these RFPs: honour.harlowe@mountsinai.org / 646-605-8715

12/16/2020 - Alex’s Lemonade Stand Foundation (ALSF) / RUNX1 Research Program Early Career Investigator Grant

Alex’s Lemonade Stand Foundation (ALSF) and the RUNX1 Research Program (RRP) are pleased to announce we are now accepting applications for the 2021 RUNX1 Early Career Investigator Grants. These grants promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders that focus on RUNX1-familial platelet disorder.

Investing in Future Cohorts

ALSF and RRP believe that providing capital to early career investigators not only injects funding to where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has received limited attention.
The New RUNX1 Early Career Investigator grant provides $180,000 over three years. It’s designed to fund research leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FPD.
Collaboration and data sharing are a priority for this research program and an expected outcome of a completed project. The full application will require a resource sharing form.

Application Deadline: December 16, 2020

More Information

12/31/2020 - THRIVE Grant

The THRIVE grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and/or other major granting institutions.

Letter of Intent Deadline: December 31, 2020

More Information

GCO Funding Opportunities

Monthly and continuous submission funding opportunity packets are available on the GCO Funding Opportunities web page.

STAY CONNECTED

Sign up for the Research Listserv to stay up to date with the latest news and events.